Alzheimer's research & therapy

Gut lining enzyme Dicer1 influences gut bacteria and Alzheimer's signs in genetically modified mice

Updated

Abstract

Essence

Deleting intestinal epithelial altered the gut and brain microbiome and reduced several Alzheimer's-related brain pathologies in App-knock-in mice.

Evidence

This animal study used intestinal epithelial Dicer1 conditional knockout in App-knock-in mice plus 16S sequencing, molecular assays, and behavior testing, and found lower brain Aβ load, reduced gut inflammation, changes in BBB-related LRP1 and ABCB1, and altered brain inflammatory and metabolic transcripts.

Caveat

Because the evidence comes from a mouse knockout model, and anxiety increased without cognitive improvement, the findings do not show that this strategy will improve human Alzheimer's symptoms.

Simplified

Key numbers

10.53% ± 0.44% vs. 15.29% ± 0.55%
Reduction in Aβ Coverage in Brain
Aβ coverage in -deleted vs. control mice in the .
4.522 ± 0.851 × 10 vs. 9.167 ± 1.776 × 10
Reduction in Gut Bacteria
Bacterial levels in -deleted vs. control mice.

Key figures

Fig. 1
Gut gene transcription and cecum morphology in with and without intestinal deletion
Highlights reduced inflammatory gene transcription and preserved gut morphology after intestinal Dicer1 deletion in model mice
13195_2025_1849_Fig1_HTML
  • Panels A-F
    Gene transcription levels of Dicer1, , Occludin, Claudin1, Claudin2, and Claudin3 in cecum tissue; Dicer1 and Claudin1 transcription are significantly reduced in Dicer1-deleted (ko) mice
  • Panel G
    Immunofluorescence images of cecum showing ZO1 protein (red) localization; morphology appears similar between wild-type (wt) and Dicer1-deleted (ko) mice
  • Panels H-M
    Transcription levels of inflammatory genes Tnf-α, Il-1β, Inos, Ccl-2, Il-10, and Aif1 in cecum tissue; Tnf-α, Il-1β, Inos, and Aif1 are significantly reduced in ko mice
  • Panels N-R
    Transcription levels of T cell differentiation markers Il-17a, Rorc, Ifn-γ, Il-4, and Il-10 in cecum tissue; no significant changes between wt and ko mice
Fig. 2
Gut bacterial richness, diversity, composition, and predicted functions in with vs without intestinal deletion
Highlights reduced bacterial richness and altered gut microbiome composition linked to intestinal Dicer1 deletion in model mice
13195_2025_1849_Fig2_HTML
  • Panel A
    Total bacterial DNA amount measured by qPCR, showing lower levels in ko mice
  • Panels B-F
    (Sobs, Ace, Chao, Shannon) significantly decreased in ko mice, while Simpson's index did not change
  • Panel G
    (PCoA) of gut bacterial -level composition showing distinct clustering between wt and ko mice
  • Panel H
    Bar plots of relative abundance (%) at genus level with Wilcoxon rank-sum tests showing altered proportions of several genera (e.g., Prevotellaceae_UCG-001, Helicobacter, Parasutterella) in ko mice
  • Panel I
    prediction of bacterial metagenome functions indicating increased proportions related to nervous system and neurodegenerative diseases in ko mice
Fig. 3
Brain microbiome differences in with and without intestinal deletion
Highlights increased bacterial diversity and specific abundance in brain microbiome after intestinal Dicer1 deletion
13195_2025_1849_Fig3_HTML
  • Panel A
    Amount of bacterial normalized to host DNA is lower in ko mice than wt mice
  • Panels B and C
    and (measures of bacterial diversity) are significantly higher in ko mice than wt mice
  • Panel D
    Strong positive correlation between Chao index and observed features across samples
  • Panel E
    shows no visible difference in bacterial composition at genus level between wt and ko mice
  • Panels F to O
    Abundance of multiple bacterial genera (Agathobacter, Akkermansia, Bradyrhizobium, Desulfovibrio, Diaphorobacter, Escherichia-Shigella, Novosphingobium, Paenibacillus, Prevotella, Lachnospiraceae_UCG-001) is significantly higher in ko mice than wt mice
Fig. 4
Knock-in mice with and without intestinal deletion: brain amyloid beta levels and deposits
Highlights reduced amyloid beta deposits and soluble Aβ levels in brains of mice lacking intestinal Dicer1
13195_2025_1849_Fig4_HTML
  • Panel A
    Brain sections stained for human Aβ in ; ko (Dicer1 deletion) appears to have visibly less red Aβ deposits than wt
  • Panels B and C
    Quantification of Aβ coverage (%) in hippocampus and ; ko group shows significantly lower Aβ coverage than wt
  • Panels D, E, and F
    42 concentrations measured by in brain fractions: TBS and TBS-T soluble fractions show significantly lower Aβ42 in ko versus wt; guanidine-HCl fraction shows no significant difference
  • Panels G, H, and I
    Aβ40 concentrations measured by ELISA in brain fractions: TBS and TBS-T soluble fractions show significantly lower Aβ40 in ko versus wt; guanidine-HCl fraction shows no significant difference
1 / 4

Full Text

What this is

  • This research investigates the role of intestinal , an enzyme involved in microRNA production, in regulating the gut microbiome and () pathology in App-knock-in mice.
  • By deleting specifically in intestinal epithelial cells, the study examines changes in gut bacteria composition and their potential effects on -related brain changes.
  • Findings suggest that deletion alters the gut microbiome, reduces amyloid-beta (Aβ) levels in the brain, and may influence anxiety without improving cognitive function.

Essence

  • Deletion of in intestinal epithelial cells alters gut microbiome composition and reduces Aβ pathology in the brain of App-knock-in mice, while inducing anxiety symptoms.

Key takeaways

  • deletion significantly reduced the number of gut bacteria and altered their composition in App-knock-in mice, indicating its role in microbiome regulation.
  • Aβ coverage in the brain was significantly lower in -deleted mice compared to controls, suggesting a potential mechanism for reducing pathology.
  • Behavioral tests revealed increased anxiety in -deleted mice, with no improvement in cognitive function, highlighting a complex relationship between gut microbiome changes and behavior.

Caveats

  • The study's findings are based on a specific mouse model, which may not fully replicate human pathology or microbiome dynamics.
  • deletion led to a non-specific reduction of miRNA in the gut, limiting the ability to pinpoint which specific miRNAs might be therapeutically beneficial.

Definitions

  • Dicer1: An enzyme that processes precursor microRNAs into mature microRNAs, playing a crucial role in gene regulation.
  • Alzheimer's disease (AD): A progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and the accumulation of amyloid-beta plaques in the brain.

Simplified

Funding

Competing interests

0 of 10
authors report competing interests
10 report none
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free